US 12,064,620 B2
Neural stimulation dosing
John Louis Parker, Artarmon (AU)
Assigned to Saluda Medical Pty Ltd, Macquarie Park (AU)
Filed by Saluda Medical Pty Ltd, Level (AU)
Filed on May 15, 2023, as Appl. No. 18/317,715.
Application 18/317,715 is a continuation of application No. 17/234,678, filed on Apr. 19, 2021, abandoned.
Application 17/234,678 is a continuation of application No. 16/823,296, filed on Mar. 18, 2020, granted, now 11,167,129, issued on Nov. 9, 2021.
Application 16/823,296 is a continuation of application No. 15/327,981, granted, now 10,632,307, issued on Apr. 28, 2020, previously published as PCT/AU2015/050422, filed on Jul. 27, 2015.
Claims priority of application No. 2014902897 (AU), filed on Jul. 25, 2014; and application No. 2015900912 (AU), filed on Mar. 13, 2015.
Prior Publication US 2023/0364417 A1, Nov. 16, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/05 (2006.01); A61N 1/06 (2006.01); A61N 1/36 (2006.01); A61N 1/372 (2006.01)
CPC A61N 1/0551 (2013.01) [A61N 1/05 (2013.01); A61N 1/06 (2013.01); A61N 1/3605 (2013.01); A61N 1/36071 (2013.01); A61N 1/36146 (2013.01); A61N 1/36171 (2013.01); A61N 1/36175 (2013.01); A61N 1/36178 (2013.01); A61N 1/36185 (2013.01); A61N 1/37247 (2013.01); A61N 1/36021 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method of applying therapeutic neural stimuli, the method comprising:
monitoring, by a control unit, for at least one of sensory input and movement of a user by measuring neural activity upon a neural pathway of the user with at least one electrode positioned alongside the neural pathway; and
applying, by the control unit, therapeutic neural stimuli to the neural pathway with the at least one electrode based on the at least one of sensory input and movement of the user,
wherein the measured neural activity comprises non-evoked neural activity.